Coagulation

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

Anticoagulation in Pregnant Women: Which Medications are Safe?

By: Diana Gritsenko, PharmD Candidate 2015 - Multiple complications can arise during pregnancy. While venous thromboembolism (VTE) has a prevalence…

12 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Liposomal Doxorubicin For Liver Cancer

By Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 - Over the last two decades, there has been an increasing focus…

14 years ago